Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Spanish Ebola Patient Gets Experimental Drug

August 11, 2014 8:00 am | by CIARAN GILES, Associated Press; MARIA CHENG, Associated Press | News | Comments

Spain has imported a U.S.-made experimental Ebola drug to treat a Spanish missionary priest evacuated from Liberia last week after testing positive for the killer virus. The Health Ministry announced Monday that the ZMapp drug, made by Mapp Biopharmaceutical Inc. of San Diego, was obtained in Geneva this weekend and brought to Madrid to treat Miguel Pajares.

TOPICS:

China Jails British-US Investigator Couple

August 8, 2014 1:29 pm | News | Comments

A Briton and an American were sentenced to prison on Friday on charges of illegally trading in the personal details of Chinese citizens after they testified they bought such information to help companies combat fraud.          

TOPICS:

Genentech Submits Supplemental Biologics License Application to FDA for Lucentis Indication in Diabetic Retinopathy

August 8, 2014 11:39 am | News | Comments

The submission is based on results of the RISE and RIDE Phase III clinical trials demonstrating the safety and efficacy of Lucentis for this serious eye disease. There are currently no ocular medications approved for the treatment of diabetic retinopathy.

TOPICS:
Advertisement

Low Vitamin D Level Could Double Alzheimer's Risk, Study Finds

August 8, 2014 9:03 am | Videos | Comments

Older adults with too little vitamin D in their blood may have twice the risk of developing Alzheimer's disease as seniors with sufficient levels of the "sunshine vitamin," a new study finds.          

TOPICS:

Pancreatic Cancer Survival Rates Stagnate Since 1970's

August 8, 2014 8:55 am | Videos | Comments

Long-term survival rates of pancreatic cancer have barely improved in forty years.                            

TOPICS:

Metrics Contract Service Reveals New Name and Logo

August 8, 2014 8:44 am | News | Comments

Metrics Contract Services, a full-service contract pharmaceutical formulation development and manufacturing organization, has adopted a new and more descriptive name.              

TOPICS:

Regeneca Worldwide Recalls RegenESlim Appetite Control Capsules

August 8, 2014 8:31 am | News | Comments

Regeneca Worldwide a division of VivaCeuticals, Inc. Las Vegas, NV is conducting a voluntary nationwide recall of its RegenESlim appetite control dietary supplement from lot # EX0616R15814 and lot #11414RE5516 because FDA analysis confirmed the presence of DMAA. 

TOPICS:

CDC Director: Scale of Ebola Crisis Unprecedented

August 8, 2014 8:25 am | by LAURAN NEERGAARD, AP Medical Writer | News | Comments

The current Ebola crisis in West Africa is on pace to sicken more people than all other previous outbreaks of the disease combined, the health official leading the U.S. response said Thursday. The next few weeks will be critical, said Dr. Tom Frieden, director of the CDC, which is sending more workers into the affected countries to help.

TOPICS:
Advertisement

WHO: Ebola Outbreak is a Public Health Emergency

August 8, 2014 8:20 am | by MARIA CHENG, AP Medical Writer | News | Comments

The World Health Organization on Friday declared the Ebola outbreak in West Africa to be an international public health emergency that requires an extraordinary response to stop its spread.          

TOPICS:

FDA Lifts Hold on Experimental Ebola Drug

August 8, 2014 8:13 am | by MATTHEW PERRONE, AP Health Writer | News | Comments

U.S. health authorities have eased safety restrictions on an experimental drug to treat Ebola, a move that could clear the way for its use in patients infected with the deadly virus. Canadian drugmaker Tekmira Pharmaceuticals said the FDA modified a hold recently placed on the company's drug after safety issues emerged in human testing.

TOPICS:

U.S. Government Exercises $18.9M Contract Option for Emergent BioSolutions' Vaccinia Immune Globulin Intravenous Program

August 8, 2014 8:08 am | News | Comments

Emergent BioSolutions announced today that the Centers for Disease Control and Prevention (CDC) has exercised options under contract 200-2012-52242 for the supply of Vaccinia Immune Globulin Intravenous (VIGIV) into the U.S. Strategic National Stockpile (SNS).

TOPICS:

British-US Investigative Couple on Trial in China

August 8, 2014 12:30 am | by The Associated Press | News | Comments

A British man on trial with his American wife for illegally obtaining and selling private information about Chinese nationals says he buys such information from other consulting companies. Peter William Humphrey made the comments Friday after his trial opened in Shanghai.

TOPICS:

Bad Bite: A Tick Can Make You Allergic to Red Meat

August 7, 2014 2:22 pm | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

A bug can turn you into a vegetarian, or at least make you swear off red meat. Doctors across the nation are seeing a surge of sudden meat allergies in people bitten by a certain kind of tick. This bizarre problem was only discovered a few years ago but is growing as the ticks spread from the Southwest and the East to more parts of the United States.

TOPICS:

No Ebola Drug for Africans; Troops Deployed

August 7, 2014 2:05 pm | by JONATHAN PAYE-LAYLEH, Associated Press | News | Comments

West Africans battling to contain the spread of Ebola will have to wait for months until a potentially life-saving experimental drug used on two Americans infected with the dreaded disease could even be made, officials said. Soldiers in two of the affected countries deployed Thursday to try to stem further spread of the virus.

TOPICS:

Tekni-Plex to Acquire Closure Liner and Seal Manufacturer Tech-Seal

August 7, 2014 1:55 pm | News | Comments

Tekni-Plex, Inc. announced today that it has signed an agreement to acquire the assets of Tech-Seal Products, Inc. Tech-Seal manufactures closure liners and innerseals for food, pharmaceutical, cosmetic, and industrial applications.     

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading